Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110845

Bioconversion of C-6 Sulfidopeptide Leukotrienes by the Responding Guinea Pig Ileum Determines the Time Course of its Contraction

Steven Krilis, Robert A. Lewis, E. J. Corey, and K. Frank Austen

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115

Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Chemistry, Harvard University, Cambridge, Massachusetts 02138

Find articles by Krilis, S. in: JCI | PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115

Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Chemistry, Harvard University, Cambridge, Massachusetts 02138

Find articles by Lewis, R. in: JCI | PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115

Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Chemistry, Harvard University, Cambridge, Massachusetts 02138

Find articles by Corey, E. in: JCI | PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115

Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115

Department of Chemistry, Harvard University, Cambridge, Massachusetts 02138

Find articles by Austen, K. in: JCI | PubMed | Google Scholar

Published April 1, 1983 - More info

Published in Volume 71, Issue 4 on April 1, 1983
J Clin Invest. 1983;71(4):909–915. https://doi.org/10.1172/JCI110845.
© 1983 The American Society for Clinical Investigation
Published April 1, 1983 - Version history
View PDF
Abstract

The naturally occurring sulfidopeptide leukotrienes, leukotriene (LT) C4 (LTC4) [5(S)-hydroxy - 6(R) - S - glutathionyl - 7,9 - trans, 11,14 - cis - eicosatetraenoic acid] and its cysteinylglycine (LTD4) and cysteinyl (LTE4) analogs, which are derived by peptide cleavage, differ in the concentrations required to elicit comparable contractions of the guinea pig ileum, with respective potencies of 1.2:5:1. The effect of the ongoing bioconversion of LTC4 and LTD4 on the contractile response of the guinea pig ileum to each was determined by recording the pattern of the contraction and quantitating the initial agonist and its metabolic products. The contraction was elicited by radiolabeled agonist, and its conversion products were sampled at defined intervals and resolved by their retention times on reverse-phase high performance liquid chromatography. After a latent period of 60 s. LTC4 initiated a linear response, followed by a slower, progressive response to a maximum level that was maintained without relaxation. The metabolic conversion of LTC4 was <5% during the linear phase of contraction and complete inhibition of bioconversion of LTC4 to LTD4 by the presence of serine-borate complex did not alter the pattern of the spasmogenic response. As the maximum response in the presence of serine-borate complex was three-quarters of that obtained without the inhibitor of bioconversion, the predominant response was to LTC4 itself. The spasmogenic response of the ileum to LTD4 was immediate, linear to a maximum level, and immediately followed by a marked relaxation. That the failure of LTD4 to sustain a contraction was due to its immediate, rapid, and quantitative conversion to the less potent LTE4 was established by pharmacologically inhibiting and anatomically deleting the converting activity. In the presence of L-cysteine the conversion of LTD4 to LTE4 was largely inhibited and the maximum contractile response was well maintained. After anatomic removal of the mucosa that contained the LTD4 dipeptidase activity, the longitudinal smooth muscle preparation gave a maximal response to LTD4 that was fully maintained. Thus, bioconversion is not a prerequisite for the spasmogenic activity of LTC4 and accounts for the transient response of the ileum to LTD4.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 909
page 909
icon of scanned page 910
page 910
icon of scanned page 911
page 911
icon of scanned page 912
page 912
icon of scanned page 913
page 913
icon of scanned page 914
page 914
icon of scanned page 915
page 915
Version history
  • Version 1 (April 1, 1983): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts